You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 1 - 10 of 6913 results
  1. Lactate Sensors for Continuous Physiological Monitoring

    SBC: PROFUSA, INC.            Topic: SB12A003

    The overall goal of the Phase II work is to advance novel tissue-integrating lactate sensors towards human testing as rapidly as possible (proposal does not include human testing itself). A single sensor injected subcutaneously can provide months of continuous physiological monitoring data transmitted wirelessly through near-infrared light for remote monitoring. This proposal includes activities s ...

    SBIR Phase II 2018 Department of DefenseDefense Advanced Research Projects Agency
  2. Enhancing Situational Awareness to Counter Swarming and Other Nonlinear, Dispersed Tactics Against Naval Surface Forces

    SBC: Systems & Technology Research LLC            Topic: N122117

    The Advanced Electronic Development Program (AEDP) will develop prototypes of photonic and digital components. Under AEDP, electronic equipment will be developed and prototyped, with components integrated for a capability demonstration. This work will be performed under the Phase II SBIR program.

    SBIR Phase II 2018 Department of DefenseDefense Advanced Research Projects Agency
  3. Microfluidic DNA Sequencing

    SBC: GNUBIO, INC.            Topic: NHGRI

    DESCRIPTION (provided by applicant): This is a Phase II SBIR proposal to increase the throughput of our DNA sequencing instrument to enable whole genome sequencing with high efficiency and accuracy for a cost of under 1000 per genome. In Phase I, we developed a working sequencing assay, a microfluidic platform and camera system, and analysis methodology that enable genome alignment and variant ca ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  4. Serum Hepcidin Immunoassay: Laboratory to Marketplace

    SBC: INTRINSIC LIFESCIENCES            Topic: NIDDK

    DESCRIPTION (provided by applicant): Disorders of iron metabolism are among the most common human diseases. During the last decade, rapid progress has been made in understanding the molecular basis of iron homeostasis and its disorders. The peptide hormonehepcidin has emerged as the master regulator of iron metabolism. Dysregulation of hepcidin is the principal or contributing factor in most syste ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  5. Serum Hepcidin Immunoassay: Laboratory to Marketplace

    SBC: INTRINSIC LIFESCIENCES            Topic: 300

    DESCRIPTION provided by applicant Disorders of iron metabolism are among the most common human diseases During the last decade rapid progress has been made in understanding the molecular basis of iron homeostasis and its disorders The peptide hormone hepcidin has emerged as the master regulator of iron metabolism Dysregulation of hepcidin is the principal or contributing factor in most syst ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  6. RandD- MEDICAL: BIOMEDICAL (BASIC RESEARCH)

    SBC: IMMUNETICS, INC.            Topic: NHLBI

    This project is aimed at the development of an enzyme immunoassay (ELISA) for screening blood for antibodies to Babesia microti. Human babesiosis is a malaria-like illness due to infection of red blood cells by various species of protozoan parasites belonging to the genus Babesia. Most human infections reported in the United States are caused by B. microti which is endemic in parts of the northeas ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  7. Foveated Video Object Recognition

    SBC: MAYACHITRA, INC.            Topic: N14AT008

    Low resolution quality of operational data, size of objects of interest, view occlusions, and crowded scenes degrade the performance of state-of-art region saliency and object recognition approaches when applied to overhead sensor data. We have developed a technology to automatically detect and recognize multitude of objects of potential interest providing an object recognition decision with a hig ...

    SBIR Phase II 2018 Department of DefenseNavy
  8. TDP-43 aggregation inhibitors for the treatment of ALS

    SBC: Aquinnah Pharmaceuticals Inc.            Topic: 105

    Abstract Amyotrophic Lateral SclerosisALSis a universally fatal neurodegenerative disease that afflicts overout of everyindividualsProtein aggregation has been implicated as a primary driving force in ALS and multiple other neurodegenerative illnessesTDPis the principle component of the protein aggregates in ALSand TDPalso stands out as the only genetically defined ALS mutant gene that is also the ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  9. Supportive Clinical Trial Tasks for Nanotechnology-Based Treatment of Oral Cancer

    SBC: PRIVO TECHNOLOGIES, LLC            Topic: NCI

    Preceding Award: NCI Award 1R44CA192875-02 Project Summary: According to the Oral Cancer Foundation, about 50,000 people in the US will be newly diagnosed with oral cancer (OC) in 2017, causing 9,700 deaths[1]. OC is a severely neglected orphan disease with a lack of significant treatment advances in 4 decades[1]. Historically, OC has been present in heavy smokers and drinkers. However, more recen ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  10. A fully integrated assay and platform for detecting Clostridium difficile.

    SBC: CLAREMONT BIOSOLUTIONS LLC            Topic: NIAID

    DESCRIPTION (provided by applicant): The primary goal of this proposed project is to develop a point-of-care diagnostic assay and platform for the detection of Clostridium difficile from human stool. Two additional goals are to detect the hypervirulent strain of C. difficile B1/NAP/027 and to detect C. difficile spores from swabs of medical devices. C. difficile associated disease (CDAD) is now th ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government